TBK1 and fatty liver disease: Elevated TBK1 phosphorylation, a downstream target of STING, has been observed in HFD-fed mice, and inhibiting TBK1 via amlexanox or gene knockout significantly reduced hepatic steatosis, inflammation, and macrophage infiltration (102, 119).